GNC (GNC) Earns Daily Media Sentiment Score of 0.23

Press coverage about GNC (NYSE:GNC) has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. GNC earned a news sentiment score of 0.23 on Accern’s scale. Accern also gave media headlines about the specialty retailer an impact score of 45.4449952008624 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Here are some of the media headlines that may have impacted Accern Sentiment Analysis’s rankings:

How to Become a New Pot Stock Millionaire

GNC has been the topic of several research reports. Zacks Investment Research raised shares of GNC from a “sell” rating to a “hold” rating in a research note on Tuesday, January 23rd. JPMorgan Chase decreased their price target on shares of GNC from $7.00 to $6.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 14th. Finally, ValuEngine downgraded shares of GNC from a “strong-buy” rating to a “buy” rating in a research note on Thursday, December 21st. Four investment analysts have rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. GNC has an average rating of “Hold” and a consensus target price of $7.77.

Shares of NYSE:GNC traded down $0.13 during midday trading on Friday, hitting $3.56. The company’s stock had a trading volume of 2,298,791 shares, compared to its average volume of 2,430,668. The company has a current ratio of 2.83, a quick ratio of 0.89 and a debt-to-equity ratio of -8.01. The company has a market cap of $308.71, a P/E ratio of 2.64 and a beta of 0.88. GNC has a 12-month low of $3.13 and a 12-month high of $10.95.

GNC (NYSE:GNC) last posted its quarterly earnings results on Tuesday, February 13th. The specialty retailer reported $0.25 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.25. GNC had a negative net margin of 6.07% and a negative return on equity of 120.93%. The firm had revenue of $557.74 million for the quarter, compared to the consensus estimate of $568.80 million. During the same period last year, the firm posted $0.07 earnings per share. The company’s revenue for the quarter was down 2.1% on a year-over-year basis. analysts expect that GNC will post 0.94 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This news story was posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3339059/gnc-gnc-earns-daily-media-sentiment-score-of-0-23.html.

About GNC

GNC Holdings, Inc is a specialty retailer of health, wellness and performance products, which include protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. The Company’s operations consist of purchasing raw materials, formulating and manufacturing products and selling the finished products.

Insider Buying and Selling by Quarter for GNC (NYSE:GNC)

Receive News & Ratings for GNC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

KNOT Offshore Partners  Upgraded to “Hold” by Zacks Investment Research
KNOT Offshore Partners Upgraded to “Hold” by Zacks Investment Research
Morgan Stanley Analysts Give Siemens Healthineers  a €34.00 Price Target
Morgan Stanley Analysts Give Siemens Healthineers a €34.00 Price Target
Sartorius  Given a €120.00 Price Target by Deutsche Bank Analysts
Sartorius Given a €120.00 Price Target by Deutsche Bank Analysts
Loxo Oncology  Downgraded to “Hold” at Zacks Investment Research
Loxo Oncology Downgraded to “Hold” at Zacks Investment Research
DECENT  Price Hits $0.81 on Major Exchanges
DECENT Price Hits $0.81 on Major Exchanges
General Motors  Plans $0.38 Quarterly Dividend
General Motors Plans $0.38 Quarterly Dividend


© 2006-2018 Ticker Report. Google+.